| abstract |
The invention relates to pharmaceutical compositions for oral application which contain ibandronat and are well tolerated, or a physiologically tolerated salt thereof in the form of an active ingredient. The form of administration consists of an inner section containing the active ingredient and surrounded by a coating, free of the active ingredient, in such a manner that the active ingredient is released rapidly. |